---
figid: PMC3962777__nihms557917f2
figtitle: NEW STRATEGIES FOR TRIPLE NEGATIVE BREAST CANCER – DECIPHERING THE HETEROGENEITY
organisms:
- NA
pmcid: PMC3962777
filename: nihms557917f2.jpg
figlink: /pmc/articles/PMC3962777/figure/F2/
number: F2
caption: 'Current and future potential therapeutic targets in TNBC include: modulation
  of homologous recombination repair mechanism deficiency (platinum alkylators, PARP
  inhibitors [yellow], Chk1/2 inhibitors [blue]), modulation of p53 family signaling
  (PI3K/Akt/mTOR inhibitors [red], Chk1/2 inhibitors, Wee1 inhibitors [blue]), modulation
  of androgen receptor (PI3K/Akt/mTOR inhibitors [red], AR antagonists [dark green]),
  modulation of MAPK/MEK pathway (MEK inhibitors [light green]).'
papertitle: NEW STRATEGIES FOR TRIPLE NEGATIVE BREAST CANCER – DECIPHERING THE HETEROGENEITY.
reftext: Ingrid A. Mayer, et al. Clin Cancer Res. ;20(4):782-790.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9525194
figid_alias: PMC3962777__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3962777__F2
ndex: 1cec84b8-dee9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3962777__nihms557917f2.html
  '@type': Dataset
  description: 'Current and future potential therapeutic targets in TNBC include:
    modulation of homologous recombination repair mechanism deficiency (platinum alkylators,
    PARP inhibitors [yellow], Chk1/2 inhibitors [blue]), modulation of p53 family
    signaling (PI3K/Akt/mTOR inhibitors [red], Chk1/2 inhibitors, Wee1 inhibitors
    [blue]), modulation of androgen receptor (PI3K/Akt/mTOR inhibitors [red], AR antagonists
    [dark green]), modulation of MAPK/MEK pathway (MEK inhibitors [light green]).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KDR
  - FLT1
  - FLT4
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EGFR
  - PDGFRB
  - PDGFRA
  - PTEN
  - INPP4B
  - PTPN12
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - CHEK1
  - WEE1
  - WEE2
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - ATM
  - AR
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - TP53
  - TP63
  - TP73
  - BPIFA4P
  - BRCA2
  - BRCA1
  - WARS1
  - tyrosine
  - Breast cancer
  - Cancer
  - Lung cancer
---
